INS and Hepatic fibrosis: The severe consequences resulting from steatosis presence in CHC including increased risk of hepatic fibrosis and/or HCC, as well as decreased virologic response to antiviral therapy, all stress the urgency of investigating the complex derangements in host insulin and lipid metabolism.